Cargando…

Acute Metabolic Effects of Exenatide in Patients With Type 1 Diabetes With and Without Residual Insulin to Oral and Intravenous Glucose Challenges

OBJECTIVE: Glucagon-like peptide 1 (GLP-1) is an incretin hormone that is released from the gastrointestinal tract. Treatment with GLP-1 analogs has proven to be of clinical use for patients with type 2 diabetes. Patients with type 1 diabetes, particularly those with residual β-cell function, may al...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghazi, Tara, Rink, Linda, Sherr, Jennifer L., Herold, Kevan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968447/
https://www.ncbi.nlm.nih.gov/pubmed/23939544
http://dx.doi.org/10.2337/dc13-1169

Ejemplares similares